Top

Published in:

01-08-2019 | Care

A comparison of two models of follow-up care for adult survivors of childhood cancer

Authors: K. Reynolds, M. Spavor, Y. Brandelli, C. Kwok, Y. Li, M. Disciglio, L. E. Carlson, F. Schulte, R. Anderson, P. Grundy, J. Giese-Davis

Published in: Journal of Cancer Survivorship | Issue 4/2019

Abstract

Purpose

Few studies have compared follow-up-care models for adult survivors of childhood cancer (ASCCs), though choice of model could impact medical test adherence, and health-related quality of life (QOL). This study compared two follow-up-care models, cancer-center-based versus community-based, for ASCCs in Alberta, Canada, to determine which model would demonstrate greater ASCC adherence to guideline-recommended medical screening tests for late effects, QOL, physical symptoms, and adherence to yearly follow-up.

Methods

ASCC discharged to a community model (over 15 years) and those with comparable birth years (1973–1993) currently followed in a cancer center model were recruited via direct contact or multimedia campaign. Chart review identified chemotherapeutic and radiation exposures, and required medical late effect screening tests. ASCCs also completed questionnaires assessing QOL, physical symptoms, and follow-up behavior.

Results

One hundred fifty-six survivors participated (community (n = 86); cancer center (n = 70)). Primary analysis indicated that cancer center ASCCs guideline-recommended total test adherence percentage (Mdn = 85.4%) was significantly higher than the community model (Mdn = 29.2%, U = 3996.50, p < 0.0001). There was no significant difference in QOL for cancer center ASCCs (M = 83.85, SD = 20.55 versus M = 77.50, SD = 23.94; t (154) = 1.77, p = 0.078) compared to community-based ASCCs. Cancer center–based ASCCs endorsed from 0.4–7.1% fewer physical symptom clusters, and higher adherence to follow-up behavior in comparisons using effect sizes without p values.

Conclusion

This study highlights the cancer center model’s superiority for adherence to exposure-based medical late effect screening guidelines, cancer-specific follow-up behaviors, and the reporting of fewer physical complaints in ASCCs.

Implications for cancer survivors

ASCCs followed in a cancer center model likely benefit from earlier late-effects detection and opportunities for early intervention.

Available only for authorised users

Armstrong GT, Yasui Y, Chen Y, Leisenring WM, Gibson TM, Mertens A, et al. Reduction in late mortality among 5-year survivors of childhood cancer: a report from the Childhood Cancer Survivor Study (CCSS). N Engl J Med. 2016;374(9):833–42. https://doi.org/10.1056/NEJMoa1510795.CrossRefPubMedPubMedCentral

Freyer DR. Transition of care for young adult survivors of childhood and adolescent cancer: rationale and approaches. J Clin Oncol. 2010;28(32):4810–8. https://doi.org/10.1200/JCO.2009.23.4278.CrossRefPubMedPubMedCentral

Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103. https://doi.org/10.3322/caac.21219.CrossRefPubMed

Hudson MM, Gurney JG, Nathan PC, Leisenring W, Robison LL, Ness KK, et al. Age-dependent changes in health status in the childhood cancer survivor cohort. J Clin Oncol. 2015;33(5):479–91. https://doi.org/10.1200/JCO.2014.57.4863.CrossRefPubMed

National Research Council. Childhood cancer survivorship: improving care and quality of life. Washington, D.C.: Natl Acad Press; 2003.

Landier W, Constine LS, Freeman CR, Friedman DL, Green DM, Marina N, et al. Development of risk-based guidelines for pediatric cancer survivors: the children’s oncology group long-term follow-up guidelines from the children’s oncology group late effects committee and nursing discipline. J Clin Oncol. 2004;22(24):4979–90. https://doi.org/10.1200/JCO.2004.11.032.CrossRefPubMed

Armstrong GT, Robison LL, Liu W, Leisenring W, Yasui Y, Hammond S, et al. Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2011;29(22):3056–64. https://doi.org/10.1200/JCO.2011.34.6585.CrossRefPubMedPubMedCentral

Pole JD, Gu LY, Kirsh V, Greenberg ML, Nathan PC. Subsequent malignant neoplasms in a population-based cohort of pediatric cancer patients: a focus on the first 5 years. Cancer Epidemiol Biomark Prev. 2015;24(10):1585–92. https://doi.org/10.1158/1055-9965.epi-15-0360.CrossRef

Friedman DL, Neglia JP, Whitton J, Leisenring W, Mertens AC, Hammond S, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010;102(14):1083–95. https://doi.org/10.1093/jnci/djq238.CrossRefPubMedPubMedCentral

10.

Veiga LHS, Hammond S, Neglia JP, Meadows AT, Donaldson SS, Sklar CA, et al. Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study. Cancer Epidemiol Biomark Prev. 2012;21(1):92–101. https://doi.org/10.1158/1055-9965.EPI-11-0576.CrossRef

11.

Bhatti P, Veiga LH, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, et al. Risk of second primary thyroid cancer after radiotherapy for a child cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res. 2010;174(6):741–52. https://doi.org/10.1667/RR2240.1.CrossRefPubMedPubMedCentral

12.

Brabant G, Toogood AA, Shalet SM, Frobisher C, Lancashire ER, Reulen RC, et al. Hypothyroidism following childhood cancer therapy-an under diagnosed complication. Int J Cancer. 2012;130(5):1145–50. https://doi.org/10.1002/ijc.26086.CrossRefPubMed

13.

Neville KA, Cohn RJ, Steinbeck KS, Johnston K, Walker JL. Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. J Clin Endocrinol Metab. 2006;91(11):4401–7.CrossRefPubMed

14.

Brignardello E, Felicetti F, Castiglione A, Chiabotto P, Corrias A, Fagioli F, et al. Endocrine health conditions in adult survivors of childhood cancer: the need for specialized adult-focused follow-up clinics. Eur J Endocrinol. 2013;168(3):465–72. https://doi.org/10.1530/EJE-12-1043.CrossRefPubMed

15.

Record EO, Meacham LR. Survivor care for pediatric cancer survivors: a continuously evolving discipline. Curr Opin Oncol. 2015;27(4):291–6. https://doi.org/10.1097/cco.0000000000000195.CrossRefPubMed

16.

van der Pal HJ, van Dalen EC, Hauptmann M, Kok WE, Caron HN, van der Bos C, et al. Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. Arch Intern Med. 2010;170(14):1247–55. https://doi.org/10.1001/archinternmed.2010.233.CrossRefPubMed

17.

Mulrooney DA, Yeazel M, Mitby P, Kawashima T, Leinsenring WM, Stovall M. Survivors of childhood cancer may have higher risk for heart disease. ONS Connect. 2008;7.

18.

Huang TT, Chen Y, Dietz AC, Yasui Y, Donaldson SS, Stokes DC, et al. Pulmonary outcomes in survivors of childhood central nervous system malignancies: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2014;61(2):319–25. https://doi.org/10.1002/pbc.24819.CrossRefPubMed

19.

Winqvist S, Vainionpaa L, Kokkonen J, Lanning M. Cognitive functions of young adults who survived childhood cancer. Appl Neuropsychol. 2001;8(4):224–33.CrossRefPubMed

20.

Meadows AT, Gallagher JA, Bunin GR. Late effects of early childhood cancer therapy. Br J Cancer Suppl. 1992;18:S92–5.PubMedPubMedCentral

21.

Wengenroth L, Rueegg CS, Michel G, Gianinazzi ME, Essig S, von der Weid NX, et al. Concentration, working speed and memory: cognitive problems in young childhood cancer survivors and their siblings. Pediatr Blood Cancer. 2015;62(5):875–82. https://doi.org/10.1002/pbc.25396.CrossRefPubMedPubMedCentral

22.

Eilertsen ME, Rannestad T, Indredavik MS, Vik T. Psychosocial health in children and adolescents surviving cancer. Scand J Caring Sci. 2011;25(4):725–34. https://doi.org/10.1111/j.1471-6712.2011.00883.x.CrossRefPubMed

23.

Bober SL, Zhou ES, Chen B, Manley PE, Kenney LB, Recklitis CJ. Sexual function in childhood cancer survivors: a report from project REACH. J Sex Med. 2013;10:2084–93. https://doi.org/10.1111/jsm.12193.CrossRefPubMed

24.

Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2009;27(16):2677–85. https://doi.org/10.1200/JCO.2008.20.1541.CrossRefPubMedPubMedCentral

25.

Fritz GK, Williams JR. Issues of adolescent development for survivors of childhood cancer. J Am Acad Child Adolesc Psychiatry. 1988;27(6):712–5. https://doi.org/10.1097/00004583-198811000-00008.CrossRefPubMed

26.

van Casteren NJ, van der Linden GH, Hakvoort-Cammel FG, Hahlen K, Dohle GR, van den Heuvel-Eibrink MM. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr Blood Cancer. 2009;52(1):108–12. https://doi.org/10.1002/pbc.21780. CrossRefPubMed

27.

Cantrell MA, Lupinacci P. Investigating the determinants of health-related quality of life among childhood cancer survivors. J Adv Nurs. 2008;64(1):73–83. https://doi.org/10.1111/j.1365-2648.2008.04760.x.CrossRefPubMed

28.

Blaauwbroek R, Stant AD, Groenier KH, Kamps WA, Meyboom B, Postma A. Health-related quality of life and adverse late effects in adult (very) long-term childhood cancer survivors. Eur J Cancer. 2007;43(1):122–30. https://doi.org/10.1016/j.ejca.2006.08.003.CrossRefPubMed

29.

Eshelman-Kent D, Kinahan KE, Hobbie W, Landier W, Teal S, Friedman D, et al. Cancer survivorship practices, services, and delivery: a report from the Children’s Oncology Group (COG) nursing discipline, adolescent/young adult, and late effects committees. J Cancer Surviv. 2011;5(4):345–57. https://doi.org/10.1007/s11764-011-0192-8.CrossRefPubMedPubMedCentral

30.

Friedman DL, Freyer DR, Levitt GA. Models of care for survivors of childhood cancer. Pediatr Blood Cancer. 2006;46(2):159–68.CrossRefPubMed

31.

Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.CrossRefPubMed

32.

Huang IC, Krull KR, Brinkman TM, Kenzik K, Gurney JG, Ness KK, et al. Association between the prevalence of symptoms and health-related quality of life in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study. J Clin Oncol. 2013;31(33):4242–51. https://doi.org/10.1200/JCO.2012.47.8867.CrossRefPubMedPubMedCentral

33.

Kraemer HC, Kupfer DJ. Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry. 2006;59(11):990–6. https://doi.org/10.1016/j.biopsych.2005.09.014.CrossRefPubMed

34.

Marr KC, Agha M, Sutradhar R, Pole JD, Hodgson D, Guttmann A, et al. Specialized survivor clinic attendance increases adherence to cardiomyopathy screening guidelines in adult survivors of childhood cancer. J Cancer Surviv. 2017;11(5):614–23. https://doi.org/10.1007/s11764-017-0634-z.CrossRefPubMed

35.

Cox CL, Oeffinger KC, Montgomery M, Hudson MM, Mertens AC, Whitton J, et al. Determinants of mammography screening participation in adult childhood cancer survivors: results from the childhood cancer survivor study. Oncol Nurs Forum. 2009;36(3):335–44. https://doi.org/10.1188/09.onf.335-344.CrossRefPubMedPubMedCentral

36.

Mertens AC, Liu Q, Neglia JP, Wasilewski K, Leisenring W, Armstrong GT, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2008;100(19):1368–79. https://doi.org/10.1093/jnci/djn310.CrossRefPubMedPubMedCentral

37.

Berg C, Hayashi RJ. Participation and self-management strategies of young adult childhood cancer survivors. Occup Particip Health. 2013;33(1):21–30. https://doi.org/10.3928/15394492-20120607-01.CrossRef

38.

Oeffinger KC, Hudson MM. Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. CA Cancer J Clin. 2004;54:208–36.CrossRefPubMed

39.

Zheng DJ, Sint K, Mitchell HR, Kadan-Lottick NS. Patterns and predictors of survivorship clinic attendance in a population-based sample of pediatric and young adult childhood cancer survivors. J Cancer Surviv. 2016;10(3):505–13. https://doi.org/10.1007/s11764-015-0493-4.CrossRefPubMed

40.

Nathan PC, Agha M, Pole JD, Hodgson D, Guttmann A, Sutradhar R, et al. Predictors of attendance at specialized survivor clinics in a population-based cohort of adult survivors of childhood cancer. J Cancer Surviv. 2016;10(4):611–8. https://doi.org/10.1007/s11764-016-0522-y.CrossRefPubMed

41.

Smits-Seemann RR, Pettit J, Li H, Kirchhoff AC, Fluchel MN. Infection-related mortality in Hispanic and non-Hispanic children with cancer. Pediatr Blood Cancer. 2017;64(9). https://doi.org/10.1002/pbc.26502.CrossRef

42.

Barakat LP, Schwartz LA, Szabo MM, Hussey HM, Bunin GR. Factors that contribute to post-treatment follow-up care for survivors of childhood cancer. J Cancer Surviv. 2012;6(2):155–62. https://doi.org/10.1007/s11764-011-0206-6.CrossRefPubMed

43.

Michel G, Greenfield D, Absolom K, Eiser C. Satisfaction with follow-up consultations among younger adults treated for cancer: the role of quality of life and psychological variables. Psychooncology. 2011;20(8):813–22. https://doi.org/10.1002/pon.1783.CrossRefPubMed

44.

Welch JJG, Kenney LB, Hirway P, Usmani GN, Kadan-Lottick N, Grewal SS, et al. Understanding predictors of continued long-term pediatric cancer care across the region: a report from the Consortium for New England Childhood Cancer Survivors. Pediatr Blood Cancer. 2017;64(10). https://doi.org/10.1002/pbc.26564.CrossRef

45.

Klosky JL, Cash DK, Buscemi J, Lensing S, Garces-Webb DM, Zhao W, et al. Factors influencing long-term follow-up clinic attendance among survivors of childhood cancer. J Cancer Surviv. 2008;2(4):225–32. https://doi.org/10.1007/s11764-008-0063-0.CrossRefPubMedPubMedCentral

46.

Rebholz CE, von der Weid NX, Michel G, Niggli FK, Kuehni CE. Follow-up care amongst long-term childhood cancer survivors: a report from the Swiss Childhood Cancer Survivor Study. Eur J Cancer. 2011;47(2):221–9. https://doi.org/10.1016/j.ejca.2010.09.017.CrossRefPubMed

47.

Casillas J, Kahn KL, Doose M, Landier W, Bhatia S, Hernandez J, et al. Transitioning childhood cancer survivors to adult-centered healthcare: insights from parents, adolescent, and young adult survivors. Psychooncology. 2010;19(9):982–90. https://doi.org/10.1002/pon.1650.CrossRefPubMed

48.

Milam JE, Meeske K, Slaughter RI, Sherman-Bien S, Ritt-Olson A, Kuperberg A, et al. Cancer-related follow-up care among Hispanic and non-Hispanic childhood cancer survivors: The Project Forward study. Cancer. 2015;121(4):605–13. https://doi.org/10.1002/cncr.29105.CrossRefPubMed

49.

Devine KA, Viola A, Capucilli P, Sahler OJ, Andolina JR. Factors associated with noncompliance with long-term follow-up care among pediatric cancer survivors. J Pediatr Hematol Oncol. 2017;39(3):167–73. https://doi.org/10.1097/mph.0000000000000744.CrossRefPubMedPubMedCentral

50.

Smits-Seemann RR, Kaul S, Zamora ER, Wu YP, Kirchhoff AC. Barriers to follow-up care among survivors of adolescent and young adult cancer. J Cancer Surviv. 2017;11(1):126–32. https://doi.org/10.1007/s11764-016-0570-3.CrossRefPubMed

51.

Bober SL, Recklitis CJ, Campbell EG, Park ER, Kutner JS, Najita JS, et al. Caring for cancer survivors: a survey of primary care physicians. Cancer. 2009;115(18 Suppl):4409–18. https://doi.org/10.1002/cncr.24590.CrossRefPubMed

52.

Landier W, Wallace W, Hamish B, Hudson MM. Long-term follow-up of pediatric cancer survivors: education, surveillance, and screening. Pediatr Blood Cancer. 2006;46(2):149–58. https://doi.org/10.1002/pbc.20612.CrossRefPubMed

53.

Russell B, Reynolds K, Spavor M, Giese-Davis J, editors. Barriers to care in two differing models of follow-up for long-term childhood cancer survivors. Alexandria: American Society of Clinical Oncology; 2017.

54.

Maeda N, Horibe K, Kato K, Kojima S, Tsurusawa M. Survey of childhood cancer survivors who stopped follow-up physician visits. Pediatr Int. 2010;52(5):806–12. https://doi.org/10.1111/j.1442-200X.2010.03158.x.CrossRefPubMed

55.

Gianinazzi ME, Essig S, Rueegg CS, von der Weid NX, Brazzola P, Kuehni CE, et al. Information provision and information needs in adult survivors of childhood cancer. Pediatr Blood Cancer. 2014;61(2):312–8. https://doi.org/10.1002/pbc.24762.CrossRefPubMed

56.

Ristovski-Slijepcevic S, Barr R, Bernstein M, Nathan PC. A cross-Canada survey of clinical programs for the care of survivors of cancer in childhood and adolescence. Paediatr Child Health. 2009;14(6):375–8.PubMedPubMedCentral

57.

Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, D.C.: Natl Acad Press; 2006.

58.

Collie K, McCormick J, Waller AE, Railton C, Shirt L, Chobanuk J, et al. Qualitative evaluation of care plans for Canadian breast and head-and-neck cancer survivors. Curr Oncol. 2014;21(1):18–28. https://doi.org/10.3747/co.21.1698.CrossRef

59.

Stricker C, Jacobs L, Risendal B, Jones A, Panzer S, Ganz P, et al. Survivorship care planning after the Institute of Medicine recommendations: how are we faring? J Cancer Surviv. 2011;5(4):358–70. https://doi.org/10.1007/s11764-011-0196-4.CrossRefPubMedPubMedCentral

60.

Earle CC. Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol. 2006;24(32):5112–6. https://doi.org/10.1200/jco.2006.06.5284.CrossRefPubMed

61.

Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC. Comparisons of patient and physician expectations for cancer survivorship plans. J Clin Oncol. 2009;27(15):2489–93. https://doi.org/10.1200/JCO.2008.20.3232.CrossRefPubMed

62.

McCabe M, Partridge A, Grunfeld E, Hudson M. Risk-based health care, the cancer survivor, the oncologist, and the primary care physician. Semin Oncol. 2013;40(6):804–12. https://doi.org/10.1053/j.seminoncol.2013.09.004.CrossRefPubMedPubMedCentral

63.

Grunfeld E, Levine MN, Julian JA, Pond GR, Maunsell E, Folkes A, et al. Results of a multicenter randomized trial to evaluate a survivorship care plan for breast cancer survivors. J Clin Oncol. 2011;29(suppl):abstr 9005.CrossRef

64.

Brennan ME, Gormally JF, Butow P, Boyle FM, Spillane AJ. Survivorship care plans in cancer: a systematic review of care plan outcomes. Br J Cancer. 2014;111(10):1899–908. https://doi.org/10.1038/bjc.2014.505.CrossRefPubMedPubMedCentral

65.

Smith TJ, Snyder C. Is it time for (survivorship care) plan B? J Clin Oncol. 2011;29(36):4740–2. https://doi.org/10.1200/jco.2011.38.8397.CrossRefPubMed

66.

White J, Park J, Russell KB, Reynolds KA, Madani A, Carlson LE, et al. Falling through the cracks. A thematic evaluation of unmet needs of adult survivors of childhood cancers. Psychooncology. 2018;27(8):1979–86. https://doi.org/10.1002/pon.4754.CrossRefPubMed

67.

McBride ML, Sisler J, Kim G, Game L, Ozokwelu E, Gingerich JR, et al. Integrating primary care and cancer care in survivorship: a collaborative approach. J Clin Oncol. 2016;34(3_suppl):103. https://doi.org/10.1200/jco.2016.34.3_suppl.103.CrossRef

68.

Sussman J, Souter LH, Grunfeld E, Howell D, Gage C, Keller-Olaman S, et al. Models of care for cancer survivorship. Toronto: Cancer Care Ontario; 2012. Report No.: 26–1

69.

Howell D, Hack TF, Oliver TK, Chulak T, Mayo S, Aubin M, et al. Models of care for post-treatment follow-up of adult cancer survivors: a systematic review and quality appraisal of the evidence. J Cancer Surviv. 2012;6(4):359–71. https://doi.org/10.1007/s11764-012-0232-z.CrossRefPubMed

70.

Tonorezos ES, Barnea D, Cohn RJ, Cypriano MS, Fresneau BC, Haupt R, et al. Models of care for survivors of childhood cancer from across the globe: advancing survivorship care in the next decade. J Clin Oncol. 2018;36:2223–30. https://doi.org/10.1200/jco.2017.76.5180.CrossRefPubMedPubMedCentral

Title: A comparison of two models of follow-up care for adult survivors of childhood cancer
Authors: K. Reynolds
M. Spavor
Y. Brandelli
C. Kwok
Y. Li
M. Disciglio
L. E. Carlson
F. Schulte
R. Anderson
P. Grundy
J. Giese-Davis
Publication date: 01-08-2019
Publisher: Springer US
Keyword: Care
Published in: Journal of Cancer Survivorship / Issue 4/2019
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-019-00774-w

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Implications for cancer survivors

Please log in to get access to this content

Other articles of this Issue 4/2019

Preferences for cancer survivorship care among adolescents and young adults who experienced healthcare transitions and their parents

The use of mobile technology and peer navigation to promote adolescent and young adult (AYA) cancer survivorship care: results of a randomized controlled trial

Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test

Food insecurity among adult cancer survivors in the United States

Neurocognitive outcomes in long-term survivors of Wilms tumor: a report from the St. Jude Lifetime Cohort

Building a physical activity intervention into clinical care for breast and colorectal cancer survivors in Wisconsin: a randomized controlled pilot trial

Keynote webinar | Spotlight on antibody–drug conjugates in cancer